Related Experiment Videos
Atypical complex endometrial hyperplasia treated with the GyneLase system
George A Vilos1, Helen C Ettler
1Department of Obstetrics and Gynecology, University of Western Ontario, London, Ontario, Canada.
Summary
A patient with atypical endometrial hyperplasia experienced amenorrhea after treatment with hysteroscopy, curettage, and the GyneLase system. While promising, further research is needed to confirm GyneLase efficacy for endometrial hyperplasia.
Area of Science:
- Gynecology
- Reproductive Medicine
- Minimally Invasive Surgery
Background:
- Endometrial hyperplasia, particularly atypical forms, poses a risk for endometrial cancer.
- Standard treatments include hormonal therapy and hysterectomy, but minimally invasive options are being explored.
Observation:
- A 47-year-old woman with non-atypical endometrial hyperplasia progressed to atypical hyperplasia.
- She refused hysterectomy and hormonal therapy, opting for hysteroscopy, curettage, and the GyneLase system.
Findings:
- Post-treatment, the patient achieved amenorrhea with a significantly reduced endometrial echo (2 mm).
- Follicle-stimulating hormone levels indicated menopausal transition (63 IU/L).
Implications:
- The GyneLase system, in conjunction with hysteroscopy and curettage, may offer a potential treatment for atypical endometrial hyperplasia.
- Further clinical trials are essential to validate the efficacy and long-term outcomes of this approach for atypical endometrial hyperplasia.